CD4 and Kaposi's sarcoma: Studies with an ATI regularly involve exclusion criteria that seek to protect study participants, including, for example, the participant’s history of CDC category C clinical events, history of cutaneous Kaposi sarcoma, and CD4 and nadir CD4 specifications (see eg, Jean-Daniel Lelièvre and Laurent Hocqueloux’s case earlier in this supplement, [12]).